Integrated analysis of usnic acid as a potential inhibitor of dengue NS2B/NS3 protease: DFT, molecular docking, MEP, ADMET, and drug-likeness evaluation
BioTechnologia · 22.05.2026
DOI: 10.5114/bta/216303 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioTechnologia, online erschienen am 22.05.2026. Verfasst von Neni Frimayanti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sekolah Tinggi Ilmu Farmasi Riau, Pekanbaru, Riau, Indonesia. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The present study aimed to evaluate the inhibitory capability of 10 pyrazole-usnic acid derivatives against dengue virus serotype 2 (DENV-2) NS2B/NS3 serine protease. The crystallographic structure model of the protease enzyme (PDB code: 2FOM) was used to conduct molecular docking studies of pyrazole-usnic acid derivatives with target proteins. Computational analysis was performed using the Molecular Operating Environment program, Gaussian View software, and ADMETLab platform. Material and methods The inhibitory potential of the derivatives was tested by molecular docking using panduratin A as the positive control, together with density functional theory, molecular electrostatic potential analysis, drug-likeness assessment, and ADMET (absorption, distribution, metabolism, excretion, and toxicity) profiling.
Results
Among the tested derivatives, compounds 5 and 6 exhibited the most promising inhibitory effects against DENV-2 NS2B/NS3 serine protease. The binding free energy values for these compounds were –7.320 and –7.477 kcal/mol, respectively. These two compounds shared multiple amino acid residues with panduratin A, which was used as a reference inhibitor. Compounds 5 and 6 also displayed negative electrostatic regions surrounding their oxygen atoms, with gap energies of 0.133 and 0.137 eV and dipole moment values of 3.237 and 2.806 D, respectively.
Conclusions
These computational findings suggest that compounds 5 and 6 may serve as preliminary candidates for dengue virus inhibition. However, further clinical and experimental studies are required to confirm their efficacy and safety.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sekolah Tinggi Ilmu Farmasi Riau, Pekanbaru, Riau, Indonesia.
Zitieren
APA
Frimayanti, N., Ikhtiarudin, I., & Syakirah, M. (2026). Integrated analysis of usnic acid as a potential inhibitor of dengue NS2B/NS3 protease: DFT, molecular docking, MEP, ADMET, and drug-likeness evaluation. BioTechnologia. https://doi.org/10.5114/bta/216303
Vancouver
Frimayanti N, Ikhtiarudin I, Syakirah M. Integrated analysis of usnic acid as a potential inhibitor of dengue NS2B/NS3 protease: DFT, molecular docking, MEP, ADMET, and drug-likeness evaluation. BioTechnologia. 2026. doi:10.5114/bta/216303
BibTeX
@article{Frimayanti2026,
author = {Frimayanti, Neni and Ikhtiarudin, Ihsan and Syakirah, Maydhea},
title = {Integrated analysis of usnic acid as a potential inhibitor of dengue NS2B/NS3 protease: DFT, molecular docking, MEP, ADMET, and drug-likeness evaluation},
journal = {BioTechnologia},
year = {2026},
doi = {10.5114/bta/216303}
}
EUVIMED